Securities Code: 002393 Securities Abbreviation: Lifeon Pharmaceutical Announcement No.: 2026-027
Tianjin Lifeon Pharmaceutical Co., Ltd. Announcement on the Implementation of the 2025 Equity Distribution Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and are free from any false representations, misleading statements, or material omissions.
Special Notice:
- As of the date of this announcement, Tianjin Lifeon Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "this Company") holds 699,980 shares in its dedicated repurchase securities account. In accordance with the "Company Law of the People's Republic of China," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guide No. 9—Repurchase of Shares," and other relevant regulations, these shares will not participate in this profit distribution and capital reserve increase. The Company will use a base of 256,886,863 shares, which is the existing total share capital of 257,586,843 shares minus the 699,980 repurchased shares, to distribute a cash dividend of RMB 6.00 per 10 shares (tax inclusive) to all shareholders, and to transfer 2 shares from capital reserve to all shareholders per 10 shares. The total share capital after the transfer will be subject to the share registration results of China Securities Depository and Clearing Corporation Limited. No bonus shares will be issued.
- Since the shares in the Company's repurchase account do not participate in the 2025 equity distribution and capital reserve increase, the total amount of actual cash dividends distributed = total shares participating in the distribution * distribution ratio, which is 256,886,863 shares * RMB 6.00 / 10 shares = RMB 154,132,117.80. When calculating the ex-dividend price after this equity distribution, the cash dividend per 10 shares should be calculated as RMB 5.983695. Cash dividend per 10 shares = total cash dividend / total share capital (including repurchased shares) * 10 shares, which is RMB 154,132,117.80 / 257,586,843 shares * 10 shares = RMB 5.983695. The calculation result is not rounded and is kept to six decimal places. The total number of shares actually transferred = total shares participating in the transfer * 2 / 10 shares, which is 256,886,863 shares * 2 / 10 shares = 51,377,372 shares. The total share capital after the transfer will be 308,964,215 shares (subject to the share registration results of China Securities Depository and Clearing Corporation Limited). The number of shares transferred per 10 shares calculated based on the total share capital (including repurchased shares) = total transferred shares / total share capital * 10 shares = 51,377,372 shares / 257,586,843 shares * 10 shares = 1.994565 shares. To ensure the equity distribution plan remains unchanged, the ex-rights and ex-dividend reference price after the implementation of the 2025 equity distribution and capital reserve increase will be = (closing price on the equity registration date - RMB 5.983695 / 10 shares) / (1 + 1.994565 / 10 shares). The Company's 2025 equity distribution and capital reserve increase plan was approved at the 2025 Shareholders' Meeting held on April 15, 2026. The equity distribution matters are hereby announced as follows: